Sanofi signs letter of intent with Tricog Health to Power India’s Next Generation of Health Innovators
Prateek Golecha, Chief Growth Officer, Tricog Health (L) with Deepak Arora, Managing Director, Sanofi India (R)
Sanofi Healthcare India Pvt. Ltd. today signed a Letter of Intent (LOI) with Tricog Health, a Bharat Innovates startup, taking a concrete step towards enabling India's startup and entrepreneurship ecosystem. The LOI was signed in the presence of Sebastien Coisne, Finance Business Partner International Pharma - General Medicines, Sanofi and senior officials from IIT Kanpur.
Sanofi came in touch with Tricog Health at the Bharat Innovates 2026 summit where the Ministry of Education, Government of India showcased 120 of India’s best deep tech startups at a global stage in France.
Under this partnership, Sanofi will provide mentorship, market access support, and potential financial investment to Tricog, a health-tech startup that supplies virtual cardiac diagnostic tools and services that are built by combining artificial intelligence and medical expertise.
The three-year collaboration reflects a shared commitment to nurturing homegrown innovation and building a robust entrepreneurial ecosystem that can drive meaningful impact in healthcare and beyond. This partnership comes against the backdrop of the India-France Year of Innovation 2026 — a landmark bilateral initiative placing innovation at the core of the India-France relationship.
Deepak Arora, Managing Director, Sanofi (India)
"At Sanofi, we believe that the most transformative breakthroughs happen at the intersection of science, enterprise, and public purpose. This partnership with Tricog Health is a testament to our conviction in public-private collaboration as a driving force for change. We are proud to bring Sanofi's global expertise to India's brightest innovators and help them scale ideas that are pushing the boundaries of health-tech.
The Make in India story in healthcare is shifting from ambition to execution, with AI serving as the accelerator for innovation that can serve our own population and the world; and Sanofi is proud to be part of that journey. As the nation continues to strengthen its position on the global innovation map, we are excited by the possibilities that lie ahead — because when science advances, lives improve."
Prateek Golecha, Chief Growth Officer, Tricog Health
Partnering with Sanofi is an important milestone for Tricog and a strong validation of our shared belief that innovation must ultimately translate into better patient outcomes. Sanofi’s global healthcare experience, scientific ecosystem and market reach, combined with Tricog’s AI-powered cardiac diagnostic capabilities, can help us take life-saving cardiac care to many more patients, in India and beyond. In cardiovascular disease, timely detection can make the difference between life and death. Through this partnership, our ambition is simple: scale innovation faster, detect diseases earlier, and help save more lives.”
Sanofi also plans to engage with other healthcare innovators among the deep-tech ventures identified under the Bharat Innovates initiative, including those emerging from IITs and other higher education institutions, incubators, and innovation hubs across the country.
Sanofi will be extending its support to more start-ups like Tricog, such as Ahammune Biosciences Pvt. Ltd. (innovation-led drug discovery focused on developing drugs targeting skin immune system), and the Translational Health Science and Technology Institute (an institute of biotechnology research and innovation council), which are addressing some of healthcare's most pressing challenges through cutting-edge research and technology.
Got a story that Healthcare Executive should dig into? Shoot it over to arunima.rajan@hosmac.com—no PR fluff, just solid leads.